Alzheimer’s disease, a growing silent pandemic, is discussed here by Project Alzheimer’s Value Europe (PAVE), who introduce their stakeholder forum that focuses on developing new research in the field, such as emerging therapeutic & diagnostic innovations.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
A US study found higher blood pressure levels were associated with the COVID-19 pandemic, due to stay-at-home orders impacting healthy lifestyle behaviours.
Nordic countries are typically associated with high standards of living, high investment in the public health sector and low population density. Here, Biljana Stangeland...
Pascale V Guillot from Elizabeth Garrett Anderson Institute for Women’s Health, provides further analysis of stem cell therapy for brittle bone disease
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
A new study focuses on HIV data in sub-Saharan Africa, analysing the number of people living with HIV in 47 countries, the population distribution, and the locations of healthcare facilities.
Scientists have identified coronaviruses related to SARS-CoV-2 from bats sampled in Cambodia, suggesting SARS CoV-2 has a much larger geographic distribution than previously assumed.
Latest study shows people may be able to reduce their risk of atrial fibrillation by avoiding certain triggers like alcohol, in consideration of other lifestyle factors.
Through a McMaster University led study, new evidence showing a correlation between psychological stress and Crohn’s disease flare-ups has been identified.
Sarah Woolnough, CEO of Asthma UK and the British Lung Foundation, reflects on landmark research undertaken by the charity ahead of World COPD Day, including the largest ever survey of people with COPD in the UK.
A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
